Angel A. Cobo

Angel A. Cobo

Auto-generated profile, based on publicly available information

Angel A. Cobo

Department of Chemistry, University of California, One Shields Avenue, Davis, California 95616, United States

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2021 in Organic Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
YWYongchao Wang
Yongchao Wang
ACAngel A. Cobo
Angel A. Cobo
AFAnnaliese K. Franz
Annaliese K. Franz
Catalytic asymmetric MCCRs for enantioselective synthesis of spirooxindoles by using chiral phosphoric acids, amines, bifunctional thiourea/squaramides and metal-based reagents as catalysts.

27 July 2020 in Nicotine & Tobacco Research
Verified
Journal Article
Open access
PDF file
BXBaoyun Xia
Baoyun Xia
BBBenjamin C Blount
Benjamin C Blount
TGTonya Guillot
Tonya Guillot
CBChristina Brosius
Christina Brosius
YLYao Li
Yao Li
LWLanqing Wang
Lanqing Wang
The tobacco-specific nitrosamines (TSNAs) are an important group of carcinogens found in tobacco and tobacco smoke. To describe and characterize the levels of TSNAs in the Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013–2014), we present four biomarkers of TSNA exposure: N′-nitrosonornicotine, N′-nitrosoanabasine, N′-nitrosoanatabine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) which is the primary urinary metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. We measured total TSNAs in 11 522 adults who provided urine using automated solid-phase extraction coupled to isotope dilution liquid chromatography–tandem mass spectrometry. After exclusions in this current analysis, we selected 11 004 NNAL results, 10 753 N′-nitrosonornicotine results, 10 919 N′-nitrosoanatabine results, and 10 996 N′-nitrosoanabasine results for data analysis. Geometric means and correlations were calculated using SAS and SUDAAN. TSNA concentrations were associated with choice of tobacco product and frequency of use. Among established, every day, exclusive tobacco product users, the geometric mean urinary NNAL concentration was highest for smokeless tobacco users (993.3; 95% confidence interval [CI: 839.2, 1147.3] ng/g creatinine), followed by all types of combustible tobacco product users (285.4; 95% CI: [267.9, 303.0] ng/g creatinine), poly tobacco users (278.6; 95% CI: [254.9, 302.2] ng/g creatinine), and e-cigarette product users (6.3; 95% CI: [4.7, 7.9] ng/g creatinine). TSNA concentrations were higher in every day users than in intermittent users for all the tobacco product groups. Among single product users, exposure to TSNAs differed by sex, age, race/ethnicity, and education. Urinary TSNAs and nicotine metabolite biomarkers were also highly correlated. We have provided PATH Study estimates of TSNA exposure among US adult users of a variety of tobacco products. These data can inform future tobacco product and human exposure evaluations and related regulatory activities.

3 March 2022 in ACS Catalysis
Verified
Journal Article
Closed access
NBNicolas R. Ball-Jones
Nicolas R. Ball-Jones
ACAngel A. Cobo
Angel A. Cobo
BABrittany M. Armstrong
Brittany M. Armstrong
BWBenjamin Wigman
Benjamin Wigman
JFJames C. Fettinger
James C. Fettinger
AFAnnaliese K. Franz
Annaliese K. Franz

21 July 2025 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
LPLeah A. Patterson
Leah A. Patterson
DCDavid A. Coppage
David A. Coppage
SFSydney M. Figueroa
Sydney M. Figueroa
ACAngel A. Cobo
Angel A. Cobo
HOHenriette O’gEen
Henriette O’gEen
AFAnnaliese K. Franz
Annaliese K. Franz